Supplemental fibrinogen restores thrombus formation in cardiopulmonary bypass-induced platelet dysfunction ex vivo
暂无分享,去创建一个
W. Toller | G. Cvirn | E. Mahla | C. Klivinyi | A. Heinemann | T. Bärnthaler | F. Prüller | M. Schoerghuber | Polina Mantaj | Christoph Klivinyi | Michael Schoerghuber
[1] N. Rahe-meyer,et al. Efficacy of platelet transfusion in cardiac surgery , 2022, Platelets.
[2] A. Michelson,et al. Decreased platelet surface phosphatidylserine predicts increased bleeding in patients with severe factor VIII deficiency , 2020, Journal of thrombosis and haemostasis : JTH.
[3] K. Karkouti,et al. Managing the coagulopathy associated with cardiopulmonary bypass , 2020, Journal of thrombosis and haemostasis : JTH.
[4] E. Mahla,et al. Supplemental Fibrinogen Restores Platelet Inhibitor-Induced Reduction in Thrombus Formation without Altering Platelet Function: An In Vitro Study , 2020, Thrombosis and Haemostasis.
[5] M. Lordkipanidzé,et al. Advances in Platelet Function Testing—Light Transmission Aggregometry and Beyond , 2020, Journal of clinical medicine.
[6] S. Verma,et al. Platelet Transfusion in Cardiac Surgery: A Systematic Review and Meta-Analysis. , 2020, The Annals of thoracic surgery.
[7] Raja R. Palvadi,et al. Society of Cardiovascular Anesthesiologists Clinical Practice Improvement Advisory for Management of Perioperative Bleeding and Hemostasis in Cardiac Surgery Patients. , 2019, Anesthesia and analgesia.
[8] K. Kaikita,et al. Total Thrombus-Formation Analysis System (T-TAS): Clinical Application of Quantitative Analysis of Thrombus Formation in Cardiovascular Disease , 2019, Thrombosis and Haemostasis.
[9] J. Airaksinen,et al. Bleeding in Patients Treated With Ticagrelor or Clopidogrel Before Coronary Artery Bypass Grafting. , 2019, The Annals of thoracic surgery.
[10] G. Faggian,et al. Impact of preoperative thrombocytopenia on the outcome after coronary artery bypass grafting , 2019, Platelets.
[11] V. Rao,et al. Comparison of Two Major Perioperative Bleeding Scores for Cardiac Surgery Trials: Universal Definition of Perioperative Bleeding in Cardiac Surgery and European Coronary Artery Bypass Grafting Bleeding Severity Grade , 2018, Anesthesiology.
[12] L. Menicanti,et al. Platelet function after cardiac surgery and its association with severe postoperative bleeding: the PLATFORM study , 2018, Platelets.
[13] G. Faggian,et al. Variation in preoperative antithrombotic strategy, severe bleeding, and use of blood products in coronary artery bypass grafting: results from the multicentre E-CABG registry , 2018, European heart journal. Quality of care & clinical outcomes.
[14] A. Camm,et al. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. , 2018, European heart journal.
[15] J. Hammon,et al. STS/SCA/AmSECT Clinical Practice Guidelines: Anticoagulation during Cardiopulmonary Bypass. , 2018, The journal of extra-corporeal technology.
[16] S. Silvetti,et al. Fibrinogen levels compensation of thrombocytopenia-induced bleeding following cardiac surgery. , 2017, International journal of cardiology.
[17] J. Airaksinen,et al. Meta-analysis of the Sources of Bleeding after Adult Cardiac Surgery. , 2017, Journal of cardiothoracic and vascular anesthesia.
[18] D. von Lewinski,et al. Implementation of buffy‐coat‐derived pooled platelet concentrates for internal quality control of light transmission aggregometry: a proof of concept study , 2017, Journal of thrombosis and haemostasis : JTH.
[19] R. Rossaint,et al. What is the evidence for platelet transfusion in perioperative settings? , 2017, Vox sanguinis.
[20] A. Koster,et al. 2017 EACTS/EACTA Guidelines on patient blood management for adult cardiac surgery. , 2017, Journal of cardiothoracic and vascular anesthesia.
[21] A. Nierich,et al. Effect of Fibrinogen Concentrate on Intraoperative Blood Loss Among Patients With Intraoperative Bleeding During High-Risk Cardiac Surgery: A Randomized Clinical Trial , 2017, JAMA.
[22] R. Bellomo,et al. Is platelet transfusion associated with hospital-acquired infections in critically ill patients? , 2017, Critical Care.
[23] A. Berghold,et al. Does Platelet Reactivity Predict Bleeding in Patients Needing Urgent Coronary Artery Bypass Grafting During Dual Antiplatelet Therapy? , 2016, The Annals of thoracic surgery.
[24] M. Hermann,et al. Fibrinogen supplementation ex vivo increasesclot firmness comparable to platelet transfusion in thrombocytopenia. , 2016, British journal of anaesthesia.
[25] V. Rao,et al. Point-of-Care Hemostatic Testing in Cardiac Surgery: A Stepped-Wedge Clustered Randomized Controlled Trial. , 2016, Circulation.
[26] Y. Okita,et al. Randomized evaluation of fibrinogen vs placebo in complex cardiovascular surgery (REPLACE): a double-blind phase III study of haemostatic therapy. , 2016, British journal of anaesthesia.
[27] T. Stijnen,et al. Hemostatic alterations during coronary artery bypass grafting. , 2016, Thrombosis research.
[28] L. Menicanti,et al. Randomized, Double-Blinded, Placebo-Controlled Trial of Fibrinogen Concentrate Supplementation After Complex Cardiac Surgery , 2015, Journal of the American Heart Association.
[29] L. Goodnough,et al. Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy , 2014, Transfusion.
[30] S. McCluskey,et al. Platelet Dysfunction as Measured by a Point-of-Care Monitor is an Independent Predictor of High Blood Loss in Cardiac Surgery , 2014, Anesthesia and analgesia.
[31] F. Szlam,et al. Haemodilution-induced changes in coagulation and effects of haemostatic components under flow conditions. , 2013, British journal of anaesthesia.
[32] A. Schmaier,et al. Recommendations for the standardization of light transmission aggregometry: a consensus of the working party from the platelet physiology subcommittee of SSC/ISTH , 2013, Journal of thrombosis and haemostasis : JTH.
[33] Y. Dargaud,et al. Mechanisms and monitoring of bypassing agent therapy , 2012, Journal of thrombosis and haemostasis : JTH.
[34] Johannes E. Schindelin,et al. Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.
[35] B. Balkau,et al. Short-acting P2Y12 blockade to reduce platelet dysfunction and coagulopathy during experimental extracorporeal circulation and hypothermia. , 2012, British journal of anaesthesia.
[36] M. Hickey,et al. Evidence of Platelet Activation at Medically Used Hypothermia and Mechanistic Data Indicating ADP as a Key Mediator and Therapeutic Target , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[37] T. Haas,et al. Effect of fibrinogen on reversal of dilutional coagulopathy: a porcine model. , 2005, British journal of anaesthesia.
[38] P. Thiagarajan,et al. P-Selectin Expression on Platelets Determines Size and Stability of Platelet Aggregates , 2000, Circulation.
[39] R. Hillman,et al. Platelet activation and aggregation during cardiopulmonary bypass. , 1991, Anesthesiology.
[40] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[41] J. Joist,et al. Potentiation by red blood cells of shear-induced platelet aggregation: relative importance of chemical and physical mechanisms. , 1984, Blood.